Molecular Genetic Analysis of Pdr5p, a Major Yeast Multidrug Transporter
Molecular Genetic Analysis of Pdr5p, a Major Yeast Multidrug Transporter
批准号:
9376625
负责人:
John Golin
金额:
$47.0万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2020-08-31
关键词:
ATP HydrolysisATP-Binding Cassette TransportersAffinityAlanineAntibiotic ResistanceAntibioticsAntigensBackBindingBiochemicalBiochemical GeneticsBiochemical ProcessBioinformaticsBiological AssayCellsClinicalCollectionCommunicationConserved SequenceCoupledDiseaseDrug Binding SiteDrug HypersensitivityDrug TransportDrug resistanceEukaryotaFrequenciesHydrolysisLaboratoriesMalignant NeoplasmsMedicalMolecularMolecular ConformationMolecular GeneticsMutateMutationNaturePharmaceutical PreparationsPhenotypeProcessPropertyRefluxReportingResearch SupportRoleScanningSeriesSignal TransductionSiteSite-Directed MutagenesisStructureSubstrate SpecificityTransmembrane DomainUnited States National Institutes of HealthWorkXenobioticsYeastschemotherapeutic agentdesignefflux pumpextracellulargenetic analysisgenetic approachmembermulti drug transportermutantnoveloperationoverexpressionpathogenpreventtransmission process
中文摘要
项目摘要
多药转运蛋白的过表达导致广谱耐药性的增加是一种
病原体和恶性肿瘤治疗中的主要医学问题。我们使用生化和
研究Pdr5的遗传学方法,Pdr5是一种主要的酵母外排泵,它是一个大型
临床上重要的真菌ABC转运蛋白亚家族。
这项提案关注的是所有ABC出口商都面临的一个核心问题。一旦有毒药物被排出
细胞,如何防止它通过药物结合部位重新进入,这些结合部位现在面临着
胞外方向?亲和力降低10-30倍,这通常发生在
运输周期不足以排除回流。我们实验室的工作确定了Pdr5
传输是单向的,因此这种外排泵是一个分子二极管。我们还确认了
一种残基,Ser-1368,是二极管功能所必需的。产生S1368A突变体的替代
当执行一种新的二极管分析时,显示出相当大的回流。
目前的建议有两个目的:第一,结合使用突变抑制和定点定位
在突变过程中,我们将确定组成Pdr5二极管的更多残基。这些突变体将会是
使用几种生化分析方法进行了仔细的表征,其中包括一种专用于二极管功能的生化分析方法。
一个中心问题是这种转运体的两个部分是否都参与了二极管的形成,或者是否类似
其他几个生化过程的二极管功能是不对称的。这项建议的第二个目的是
对二极管进行生化表征。例如,我们将确定是否有任何底物
二极管操作的专属性。三磷酸腺苷水解酶的作用和已确定的Pdr5传递
将评估二极管功能中的界面。
英文摘要
Project Summary
Overexpression of multidrug transporters leading to increased, broad-spectrum drug resistance is a
major medical problem in the treatment of pathogens and malignant tumors. We use biochemical and
genetic approaches to study Pdr5, a major yeast efflux pump that is the founding member of a large
subfamily of clinically important fungal ABC transporters.
This proposal focuses on a central issue common to all ABC exporters. Once a toxic drug is expelled from
the cell, how is it prevented from reentry via the drug-binding sites which are now facing in an
extracellular direction? A simple 10-30 fold reduction in affinity which is typically seen during the
transport cycle is not sufficient to preclude reflux. Work in our laboratory established that Pdr5
transport is unidirectional and that this efflux pump is therefore a molecular diode. We also identified
one residue, Ser-1368 that is essential for diode function. A substitution creating a S1368A mutant
shows considerable reflux when a novel diode assay is performed.
The present proposal has two aims: First, using a combination of mutant suppression and site-directed
mutagenesis, we will identify additional residues that make up the Pdr5 diode. These mutants will be
carefully characterized using several biochemical assays including one that is specific for diode function.
A central issue is whether both halves of this transporter participate in diode formation or whether like
several other biochemical processes diode function is asymmetric. The second aim of the proposal is to
biochemically characterize the diode. For instance, we will determine whether there is any substrate
specificity to diode operation. The role of ATP hydrolysis and the well-established Pdr5 transmission
interface in diode function will be evaluated.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/femsyr/foy029
发表时间:
2018-06-01
期刊:
FEMS yeast research
影响因子:
3.2
作者:
[Rahman H, Carneglia J, Lausten M, Robertello M, Choy J, Golin J]
通讯作者:
Golin J
Molecular Genetic Analysis of Pdr5p, a Major Yeast Multidrug Transporter
-
批准号:8609939
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2006
-
负责人:John Golin
-
依托单位:
海外基金